Relationship of immunohistochemistry, copy number aberrations and epigenetic disorders with BRCAness pattern in hereditary and sporadic breast cancer
Autor: | Ana Beatriz Sánchez Heras, Isabel Chirivella González, Cecilia Egoavil Rojas, Marta Llop García, Zaida García-Casado, Inmaculada de Juan Jiménez, Gema Pérez Simó, Sarai Palanca Suela, María José Juan Fita, José Antonio López Guerrero, Ángel Segura Huerta, Rosa Murria Estal, Ana Santaballa Bertran, Eva Barragán González, Cristina Alenda Gonzalez, Pascual Bolufer Gilabert |
---|---|
Rok vydání: | 2016 |
Předmět: |
Adult
0301 basic medicine Oncology Cancer Research medicine.medical_specialty Pathology Gene Dosage Breast Neoplasms Biology Gene dosage Epigenesis Genetic 03 medical and health sciences 0302 clinical medicine Germline mutation Internal medicine microRNA Biomarkers Tumor Genetics medicine Humans Multiplex ligation-dependent probe amplification Epigenetics Genetics (clinical) Aged BRCA2 Protein BRCA1 Protein DNA Methylation Middle Aged Immunohistochemistry Gene Expression Regulation Neoplastic MicroRNAs 030104 developmental biology 030220 oncology & carcinogenesis Mutation DNA methylation Female |
Zdroj: | Familial Cancer. 15:193-200 |
ISSN: | 1573-7292 1389-9600 |
DOI: | 10.1007/s10689-015-9864-2 |
Popis: | The study aims to identify the relevance of immunohistochemistry (IHC), copy number aberrations (CNA) and epigenetic disorders in BRCAness breast cancers (BCs). We studied 95 paraffin included BCs, of which 41 carried BRCA1/BRCA2 germline mutations and 54 were non hereditary (BRCAX/Sporadic). Samples were assessed for BRCA1ness and CNAs by Multiplex Ligation-dependent Probe Amplification (MLPA); promoter methylation (PM) was assessed by methylation-specific-MLPA and the expression of miR-4417, miR-423-3p, miR-590-5p and miR-187-3p by quantitative RT-PCR. IHC markers Ki67, ER, PR, HER2, CK5/6, EGFR and CK18 were detected with specific primary antibodies (DAKO, Denmark). BRCAness association with covariates was performed using multivariate binary logistic regression (stepwise backwards Wald option). BRCA1/2 mutational status (p = 0.027), large tumor size (p = 0.041) and advanced histological grade (p = 0.017) among clinic-pathological variables; ER (p < 0.001) among IHC markers; MYC (p < 0.001) among CNA; APC (p = 0.065), ATM (p = 0.014) and RASSF1 (p = 0.044) among PM; and miR-590-5p (p = 0.001), miR-4417 (p = 0.019) and miR-423 (p = 0.013) among microRNA expression, were the selected parameters significantly related with the BRCAness status. The logistic regression performed with all these parameters selected ER+ as linked with the lack of BRCAness (p = 0.001) and MYC CNA, APC PM and miR-590-5p expression with BRCAness (p = 0.014, 0.045 and 0.007, respectively). In conclusion, the parameters ER expression, APC PM, MYC CNA and miR-590-5p expression, allowed detection of most BRCAness BCs. The identification of BRCAness can help establish a personalized medicine addressed to predict the response to specific treatments. |
Databáze: | OpenAIRE |
Externí odkaz: |